| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1a6e96e9b31b4884de31eb54deff294
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3567a931f54e0a1b49babc4fc2ee2179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_918a9e41c6a8b027ab9261f444ccf1e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adc3ac48a72bb42f4fe5353c4c1cde11 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ae4091f474715b075e683afca906d26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b53e8c0d255b999863ef4fc1c64991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50f1ffeb304a30f8d330e33ab794d5c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffe14f3b3563f89662544f4e3e41715a |
| publicationDate |
2009-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7485698-B2 |
| titleOfInvention |
Pharmaceutical composition for preventing or treating malignant glioma |
| abstract |
An object of the present invention is to provide a novel malignant glioma antitumor agent and malignant glioma antitumor agent for animals, and in order to achieve this object, in the present invention a polypeptide indicated by the following (a) or (b), or a mixture thereof, is contained in a malignant glioma antitumor agent:n (a) a polypeptide comprising the amino acid sequence represented by SEQ. ID NO. 1 or SEQ. ID NO. 2; or (b) a polypeptide comprising the amino acid sequence represented by SEQ. ID NO. 1 or SEQ. ID NO. 2 with 1 or more amino acids deleted, substituted or added, and which has malignant glioma antitumor action. |
| priorityDate |
2003-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |